NFTRH+; check out this pattern [w/ edit]
I added back Biotech related DVAX yesterday, noting a short-term bottoming pattern (trade log): "As for the chart, the daily has a little hint of a short-term bottoming pattern if…
I added back Biotech related DVAX yesterday, noting a short-term bottoming pattern (trade log): "As for the chart, the daily has a little hint of a short-term bottoming pattern if…
Well, a bear looking to get short would hope for a market bounce and so, here is a market bounce. I shorted IBB this morning (per the Trade Log) and…
We track the Biotech iShares each week, and here is the up to the minute view of a constructive situation breaking to a bullish one. From NFTRH 514 (I since…
As everybody knows, long-term interest rates have been rising since the beginning of September, well before the FOMC supposedly surprised markets with a lean to a hawkish stance (for December)…
Here is one of the inter-market views that I find interesting. The Biotech iShares is constructive vs. the QQQ on a daily chart as the ratio is above all key…
As you surely know, they don't all work this way. But trading GILD has been like clockwork for me since buying the lows in June. Buy the washout and positive…
It's been a great run off the June bottom and now all Biotech profits are booked. I'll hold general Healthcare for now, with all individual stocks in the books (except…
There was the high, tight one on Biotech iShares, IBB and then others noted on the Medical Device iShares, IHI and the general sector SPDR, XLV. Well, there ya go.…
The Biotech iShares IBB shot up on some beneficial talk out of the Trump administration and, in my opinion, on beneficial Treasury yield dynamics. So it is no coincidence that…
We have used this chart in NFTRH to gauge the state of the ongoing secular bull market in Biotech vs. other Tech. The series of higher highs and higher lows…
As to the post's title, I have no idea. What I do know is that a nice profit is in the books on a suddenly overbought GILD off of Tuesday's…
Yesterday we got the surge and then the ease into the close. Today? Err... The weekly now targets 350, barring a harsh reversal over the next 2 days. GILD was…
It's been a long time coming for the Biotech sector that has for me included some stops and starts in AMGN, GILD and IBB itself. Some profits, some losses. But…
While I currently work with all sorts of macro-fundamental indicators and inter-market ratio charts, I started out just loving the act of creating and analyzing nominal stock and market charts.…